about the author

Max Bayer

Pharma Reporter

mbayer@endpointsnews.com

author articles

Up­dat­ed: White House threat­ens ‘most fa­vored na­tion’ plan to low­er US drug prices, but many ques­tions re­main

17 hours ago
Pharma

Trump says he'll sign or­der on 'most fa­vored na­tion' drug price plans Mon­day

Yesterday
R&D
Pharma

FDA will con­vene vac­cine ad­vi­sors to dis­cuss Covid strain up­dates

5 days ago
Pharma
FDA+

From deal to dis­as­ter: Drug­mak­ers face a changed Wash­ing­ton as Trump em­braces ‘most fa­vored na­tion’ prices

5 days ago
Pharma

Even as ques­tions grow over RFK Jr.'s vac­cine pol­i­cy, BioN­Tech does­n't see ‘near-term’ im­pact

Last week
R&D
Pharma

White House bud­get re­quest would cut bil­lions at NIH and CDC, add $500M for MA­HA

Last week
Pharma
FDA+

Mod­er­na, fac­ing rev­enue miss­es and po­lit­i­cal head­winds, dis­ap­points Wall Street

Last week
R&D
Pharma

Mod­er­na ex­pands ef­fort to rein in costs in an ‘un­cer­tain en­vi­ron­ment’

Last week
R&D
Pharma

Pfiz­er CEO Bourla sug­gests phar­ma tar­iffs will fo­cus on US ad­ver­saries, not al­lies

Last week
China
Pharma

Pfiz­er launch­es a new wave of cost cuts, ex­pects $7.7B in to­tal sav­ings through 2027

Last week
Pharma

No­vavax re­sponds to FDA’s tri­al ask, with Covid vac­cine strain up­dates un­der scruti­ny

2 weeks ago
Pharma
FDA+

FDA chief Makary talks ex­pe­dit­ing drug ap­provals, RIFs and the abor­tion pill

3 weeks ago
R&D
Pharma

Halozyme sues Mer­ck, al­leg­ing in­jectable Keytru­da will in­fringe its patents

3 weeks ago
Pharma
Law

Large vac­cine mak­ers stand by their in­vest­ments de­spite US head­winds

3 weeks ago
Pharma
FDA+

FDA asks No­vavax for post-mar­ket­ing da­ta of its Covid vac­cine, de­lay­ing ap­proval

3 weeks ago
Pharma
FDA+

CMS would ab­sorb 340B drug dis­count pro­gram un­der leaked HHS re­or­ga­ni­za­tion pro­pos­al

4 weeks ago
Pharma
FDA+

CDC ad­vi­sors broad­en RSV vac­cine rec­om­men­da­tions to at-risk adults in their 50s

4 weeks ago
R&D

At ACIP hear­ing, CDC says it's 'scrap­ing' to re­spond to measles out­break; FDA com­ments on No­vavax halt

4 weeks ago
Pharma
FDA+

Trump phar­ma tar­iffs inch clos­er as ad­min­is­tra­tion con­firms US trade probe

4 weeks ago
R&D
Pharma

CDC vac­cine ad­vi­sors are set to meet this week af­ter two-month de­lay and scruti­ny from Kennedy

4 weeks ago
R&D
Pharma

Vac­cines, obe­si­ty drugs, job cuts: Take­aways from RFK Jr.'s first net­work in­ter­view as HHS chief

Last month
People
Pharma

Phar­ma CEOs warn EU of po­ten­tial ‘ex­o­dus to the US’ as trade war con­tin­ues

Last month
Pharma
Manufacturing

Min­neso­ta fed­er­al judge dis­miss­es chal­lenge from Ab­b­Vie, As­traZeneca to state's 340B law

Last month
Pharma
Law

‘This is self-in­flict­ed’: Leerink’s David Risinger on the mar­ket shock and hits to bio­phar­ma

Last month
People
FDA+
1234 Next page Last page
A service from the Financial Times